Inteligex is developing proprietary stem cell-based therapeutics to restore function in patients with spinal cord injury—a devastating condition for which there is no effective therapy—and for other diseases of the Central Nervous System. Successful outcomes from the development program would position Inteligex as the first in the world with a treatment affecting hundreds of thousands of patients worldwide.